GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
N

Naba Alsaha Medical Services Company SJSC 9546.SR · SAR

Health Care · Tadawul · 🇸🇦 Saudi Arabia

Compare

22.50

—

Close of 9 Nov 2026, in SAR

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in SAR, from our data supplier.

FY2025

Revenue

SAR 201.8m

FY2020FY2025

Net income

SAR 27.5m

FY2020FY2025

Free cash flow

−SAR 51.2m

FY2020FY2025

Shareholders' equity

SAR 222.9m

FY2020FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020
RevenueSAR 201.8mSAR 194.3mSAR 182.4mSAR 129.7mSAR 117.7mSAR 115.7m
Gross profitSAR 66.2mSAR 62.4mSAR 73.8mSAR 51.6mSAR 46.8mSAR 45.9m
Operating incomeSAR 30.8mSAR 25.2mSAR 43.0mSAR 28.3mSAR 27.0mSAR 27.6m
Net incomeSAR 27.5mSAR 21.8mSAR 52.4mSAR 26.9mSAR 25.8mSAR 26.7m
Diluted earnings per share2.622.074.992.562.462.54

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020
Total assetsSAR 385.3mSAR 324.4mSAR 276.7mSAR 170.5mSAR 158.1mSAR 145.4m
Cash and short-term investments—SAR 42.8mSAR 5.7mSAR 13.8mSAR 7.0mSAR 1.8m
Total liabilitiesSAR 162.4mSAR 124.7mSAR 96.6mSAR 40.5mSAR 55.3mSAR 67.0m
DebtSAR 120.8mSAR 91.0mSAR 48.2mSAR 22.1mSAR 33.3mSAR 49.3m
Shareholders' equitySAR 222.9mSAR 199.7mSAR 180.1mSAR 130.0mSAR 102.9mSAR 78.4m
Shares outstanding11m11m11m11m11m11m

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020
Cash from operationsSAR 26.8mSAR 35.6mSAR 29.4mSAR 35.5mSAR 30.7mSAR 6.0m
Capital spending−SAR 78.0m−SAR 38.4m−SAR 41.5m−SAR 11.1m−SAR 10.4m−SAR 39.6m
Free cash flow−SAR 51.2m−SAR 2.8m−SAR 12.1mSAR 24.4mSAR 20.4m−SAR 33.6m
Dividends paid−SAR 3.1m—−SAR 2.1m−SAR 2.1m—−SAR 1.8m

Latest quarters

By quarter end

Dec 2025Jun 2025Dec 2024Jun 2024Dec 2023Jun 2023Dec 2022Jun 2022
RevenueSAR 103.7mSAR 98.1mSAR 98.0mSAR 96.3mSAR 100.5mSAR 81.8mSAR 66.8mSAR 62.9m
Gross profitSAR 34.0mSAR 32.1mSAR 30.8mSAR 31.5mSAR 38.1mSAR 33.6mSAR 24.3mSAR 27.3m
Operating incomeSAR 16.6mSAR 14.2mSAR 9.8mSAR 14.7mSAR 24.3mSAR 18.7mSAR 12.7mSAR 15.6m
Net incomeSAR 13.3mSAR 14.2mSAR 8.7mSAR 13.0mSAR 24.6mSAR 27.8mSAR 11.5mSAR 15.4m
Diluted earnings per share1.271.350.831.242.342.641.101.47
Cash from operations—SAR 17.0mSAR 16.0mSAR 18.0mSAR 16.0mSAR 12.0mSAR 21.0mSAR 13.0m
Capital spending—−SAR 47.0m−SAR 17.0m−SAR 20.0m−SAR 33.0m−SAR 5.0m−SAR 8.0m−SAR 2.0m
Free cash flow—−SAR 30.0m−SAR 1.0m−SAR 2.0m−SAR 17.0mSAR 7.0mSAR 13.0mSAR 11.0m
Total assetsSAR 385.3mSAR 339.8mSAR 324.4mSAR 285.8mSAR 276.7mSAR 227.1mSAR 170.5mSAR 167.6m
Cash and short-term investments—SAR 6.8mSAR 42.8mSAR 9.0mSAR 5.7mSAR 8.8mSAR 13.8mSAR 8.3m
DebtSAR 120.8mSAR 86.3mSAR 88.6mSAR 51.1mSAR 44.7mSAR 15.7mSAR 17.5mSAR 5.0m
Shareholders' equitySAR 222.9mSAR 210.7mSAR 199.7mSAR 193.1mSAR 180.1mSAR 155.7mSAR 130.0mSAR 118.3m

Growth per year

Compound annual rate

3 years5 years10 years
Revenue15.9%11.8%—
Operating income2.8%2.2%—
Net income0.7%0.6%—

Average margins

Over each period

1 year3 years5 years10 years
Gross margin32.5%35.9%36.8%—
Operating margin14.1%18.0%19.3%—
Net margin12.4%18.2%19.2%—

Valuation history

At each fiscal year end

FY2025FY2024FY2023FY2022
Price to earnings9.319.06.05.6
Price to sales1.32.11.71.2

Dividends and splits

Per share, in the currency the company pays

Paid for 1 years. Last went ex-dividend on 24 Mar 2025.

FY2025FY2023
Paid in the year0.150.10
  • 3-for-2 split · 20 Nov 2023

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.